pharmaceutical investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
pharmaceutical investing Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU
pharmaceutical investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
EnerCom Announces Initial List of Presenting Companies for the 31st Annual Energy Investment Conference to be held August 17-19, 2026, in Denver, Colorado
